SCHEMBL26856882

SCHEMBL26856882

Nc1nc2ccc(-c3csc(C(=O)NCc4ccccc4)c3)cn2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 4/20 0.53
▸ PIK3CD O00329 5/20 0.52
▸ PIK3CG P48736 5/20 0.52
▸ TTK P33981 2/20 0.48
▸ MAPK1 P28482 2/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ ROCK2 O75116 1/20 0.39
▸ RPS6KA5 O75582 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ PRKCG P05129 1/20 0.39
▸ PRKACA P17612 1/20 0.39
▸ RPS6KB1 P23443 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ PRKX P51817 1/20 0.39
▸ PRKCD Q05655 1/20 0.39
▸ PRKG2 Q13237 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26857184 0.91 MMP12 (0.44) MMP12PIK3CDPIK3CGTTKMAPK1
SCHEMBL26857050 0.90 MMP12 (0.47) MMP12PIK3CDPIK3CGMAPK1LMNA
SCHEMBL26856998 0.90 PIK3CD (0.46) MMP12PIK3CDPIK3CGTTKPIK3CB
SCHEMBL26857017 0.90 MAPK1 (0.46) MMP12PIK3CDPIK3CGTTKMAPK1
SCHEMBL26856987 0.90 PIK3CG (0.46) MMP12PIK3CDPIK3CGMAPK1ADORA2A
SCHEMBL26856951 0.90 ADORA2A (0.43) MMP12PIK3CDPIK3CGTTKMAPK1
SCHEMBL26856949 0.90 MAPK1 (0.47) MMP12PIK3CDPIK3CGMAPK1ADORA2A
SCHEMBL26857011 0.89 NPC1 (0.45) MMP12PIK3CDPIK3CGTTKROCK2
SCHEMBL26857153 0.88 MMP12 (0.42) MMP12PIK3CDPIK3CGTTKMAPK1
SCHEMBL26857044 0.88 MMP12 (0.42) MMP12PIK3CDPIK3CGTTKMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 MMP12 4866/4885PIK3CD 1085/4885PIK3CG 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback